ASPA moots forming action group to strengthen presence in MEA: Our Bureau, New Delhi Wednesday, April 30, 2025, 15:30 Hrs ...

Spectra Medical introduces EndoliftX, a microfiber based non-surgical aesthetic treatment in India: Our Bureau, Mumbai ...

UK MHRA grants marketing approval for BridgeBio Pharma’s Beyonttra to treat ATTR-CM: Palo Alto, California Wednesday, April 30, 2025, 16:00 Hrs [IST] BridgeBio Pharma, Inc., a n ...

Life sciences leads all industries surveyed in prioritizing and investing in edge and quantum computing, VR/AR/XR, spatial computing, XaaS technology and modern delivery. Globally, the life sciences ...

The event will be held virtually, allowing participants to join from anywhere in the world. This timely and insightful ...

Ingelheim, Germany Wednesday, April 30, 2025, 14:00 Hrs [IST] ...

AbbVie announced the US Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA). This comes after the ...

EMA committee recommends approval of AstraZeneca’s fixed-duration Calquence-based regimens for 1st-line chronic lymphocytic leukaemia: Cambridge, UK Wednesday, April 30, 2025, 1 ...

Bayer begins phase I study targeting GPC3 with actinium-225 radiopharmaceutical in patients with advanced hepatocellular carcinoma: Berlin Wednesday, April 30, 2025, 12:00 Hrs [IS ...

US FDA grants breakthrough device designation to Roche’s companion diagnostic, VENTANA TROP2 (EPR20043) RxDx Device for non-small cell lung cancer: Basel Wednesday, April 30, 20 ...

AstraZeneca to discontinue CAPItello-280 phase III trial of Truqap in metastatic castration-resistant prostate cancer: Cambridge, UK Wednesday, April 30, 2025, 10:00 Hrs [IST] Ast ...

LIfT BioSciences, (LIfT), a rapidly emerging biotech and the global leader in neutrophil immunotherapies, announces progress in advancing the planned clinical trial for their Immunomodulatory Alpha ...